Accuracy of BRCA1/2 mutation prediction models for different ethnicities and genders: Experience in a southern Chinese cohort

World Journal of Surgery

Volumn 36, Issue 4, 2012, Pages 702-713

  Kwong, Ava ^a,b,c,d   Wong, Connie H N ^a   Suen, Dacita T K ^a   Co, Michael ^a   Kurian, Allison W ^d   West, Dee W ^d   Ford, James M ^d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Hong Kong Hereditary Breast Cancer Family Registry   (Hong Kong)

^c HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; BREAST TUMOR; ETHNOLOGY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MUTATION; OVARY TUMOR; PROGNOSIS; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; YOUNG ADULT;

EID: 84863722903     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-011-1406-y     Document Type: Article

References (56)

1. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130
2. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329-1333
3. Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694-1706
4. Pal T, Permuth-Wey J, Betts JA et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807-2816
5. Beristain E, Martinez-Bouzas C, Guerra I et al (2007) Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. Breast Cancer Res Treat 106:255-262
6. Martin AM, Blackwood MA, Antin-Ozerkis D et al (2001) Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. J Clin Oncol 19:2247-2253
7. Shah P, Robbani I, Shah O (2009) Clinicopathological study of male breast carcinoma: 24 years of experience. Ann Saudi Med 29:288-293
8. Ottini L, Rizzolo P, Zanna I et al (2009) BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy. Breast Cancer Res Treat 116:577-586
9. Kash KM, Ortega-Verdejo K, Dabney MK et al (2000) Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer. Semin Surg Oncol 18:333-338
10. McInerney-Leo A, Biesecker BB, Hadley DW et al (2005) BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. Am J Med Genet A 133A:165-169
11. Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480-1490
12. Antoniou AC, Pharoah PD, McMullan G et al (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76-83
13. Antoniou AC, Durocher F, Smith P et al (2006) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8:R3
14. Berry DA, Parmigiani G, Sanchez J et al (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227-238
15. Berry DA, Iversen ES Jr, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712
16. Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145-158
17. Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415
18. Shattuck-Eidens D, Oliphant A, McClure M et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278:1242-1250
19. Evans DG, Eccles DM, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 41:474-480
20. Weitzel JN, Lagos V, Blazer KR et al (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14:1666-1671
21. Nanda R, Schumm LP, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925-1933
22. Vogel KJ, Atchley DP, Erlichman J et al (2007) BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol 25:4635-4641
23. Kurian AW, Gong GD, John EM et al (2009) Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 18:1084-1091
24. Rubinstein WS (2004) Hereditary breast cancer in Jews. Fam Cancer 3:249-257
25. Kwong A, Wong LP, Chan KY et al (2008) Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family. Fam Cancer 7:125-133
26. Hu Z, Li WF, Liu XY et al (2008) BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases. Zhonghua Yi Xue Za Zhi 88:2383-2386
27. Han SH, Lee KR, Lee DG et al (2006) Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet 70:496-501
28. Li WF, Hu Z, Rao NY et al (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110:99-109
29. Kwong A, Wong LP, Wong HN et al (2009) Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 3:63-76
30. Ikeda N, Miyoshi Y, Yoneda K et al (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83-88
31. Thirthagiri E, Lee S, Kang P et al (2008) Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 10:R59
32. Rao NY, Hu Z, Li WF et al (2009) Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 113:467-477
33. Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1/2 Mutation Prediction Models in Asian Americans. J Clin Oncol 26(29):4752-4758
34. Rao NY, Hu Z, Yu JM et al (2008) Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients. Breast Cancer Res Treat 116:563-570
35. Panchal SM, Ennis M, Canon S, Bordeleau LJ (2008) Selecting a BRCA risk assessment model for use in a familial cancer clinic. BMC Med Genet 9:116
36. Kwong A, Wong LP, Wong HN et al (2009) A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117:683-686
37. Weitzel JN, Lagos VI, Cullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297:2587-2595
38. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301-1308
39. Peto J, Collins N, Barfoot R et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949
40. Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222-2233
41. Hou MF, Tsai KB, Fan HM et al (2000) Familial breast cancer in southern Taiwan. Kaohsiung J Med Sci 16:414-421
42. Ahn SH, Son BH, Yoon KS et al (2007) BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 245:90-95
43. Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66:8297-8308
44. Johannesdottir G, Gudmundsson J, Bergthorsson JT et al (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663-3665
45. John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869-2876
46. Liede A, Narod SA (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20:413-424
47. Euhus DM, Smith KC, Robinson L et al (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844-851
48. Marroni F, Aretini P, D'Andrea E et al (2004) Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations. J Med Genet 41:278-285
49. Antoniou AC, Hardy R, Walker L et al (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45:425-431
50. Katki HA (2006) Effect of misreported family history on Mendelian mutation prediction models. Biometrics 62:478-487
51. Barlow-Stewart K, Yeo SS, Meiser B et al (2006) Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genet Med 8:24-32
52. Zanna I, Rizzolo P, Sera F et al (2010) The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases. Eur J Hum Genet 18:856-858
53. Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, Hispanic, and other minority families in the United States. J Clin Oncol 27:1184-1190
54. Mavaddat N, Rebbeck TR, Lakhani SR et al (2010) Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res 12:R28
55. Kwong A, Wong CH, Shea C et al (2010) Choice of management of southern Chinese BRCA mutation carriers. World J Surg 34:1416-1426. doi:10.1007/s00268- 010-0477-5
56. Katki HA (2007) Incorporating medical interventions into carrier probability estimation for genetic counseling. BMC Med Genet 8:13